Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach
A year after the initial outbreak, the COVID-19 pandemic caused by SARS-CoV-2 virus remains a serious threat to global health, while current treatment options are insufficient to bring major improvements. The aim of this study is to identify repurposable drug candidates with a potential to reverse t...
Saved in:
Main Authors: | Andrea Gelemanović (Author), Tinka Vidović (Author), Višnja Stepanić (Author), Katarina Trajković (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug repurposing for rheumatoid arthritis: Identification of new drug candidates via bioinformatics and text mining analysis
by: Ulku Unal, et al.
Published: (2022) -
Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
by: Norihiro Sakai, et al.
Published: (2023) -
Repurposing Approved Drugs for Sarcopenia Based on Transcriptomics Data in Humans
by: Shuang Liang, et al.
Published: (2023) -
Candidate drug repurposing for malaria: perspectives for optimising clinical trials
by: J. Luis Espinoza
Published: (2025) -
Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
by: Joana M. O. Santos, et al.
Published: (2021)